---
figid: PMC4484411__oncotarget-06-10671-g001
figtitle: Genetic/molecular alterations of meningiomas and the signaling pathways
  targeted
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC4484411
filename: oncotarget-06-10671-g001.jpg
figlink: /pmc/articles/PMC4484411/figure/F1/
number: F1
caption: The Ras-Raf-MEK-MAPK/ERK, PI3K-Akt/PKB, PLCγ1-PKC, PLA2-COX, JAK-STAT3 and
  mTOR signaling pathways are represented in the upper part of the scheme, while the
  relationships between the pRb and p53 cell cycle associated signaling pathways are
  illustrated in the lower part of the scheme. The pathway scheme displayed was generated
  with the Ingenuity Pathway Analysis (IPA) software (Ingenuity Systems Inc., Redwood
  City, CA, USA).
papertitle: Genetic/molecular alterations of meningiomas and the signaling pathways
  targeted.
reftext: Patrícia Domingues, et al. Oncotarget. 2015 May 10;6(13):10671-10688.
year: '2015'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9224077
figid_alias: PMC4484411__F1
figtype: Figure
redirect_from: /figures/PMC4484411__F1
ndex: 7307b31e-df0b-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4484411__oncotarget-06-10671-g001.html
  '@type': Dataset
  description: The Ras-Raf-MEK-MAPK/ERK, PI3K-Akt/PKB, PLCγ1-PKC, PLA2-COX, JAK-STAT3
    and mTOR signaling pathways are represented in the upper part of the scheme, while
    the relationships between the pRb and p53 cell cycle associated signaling pathways
    are illustrated in the lower part of the scheme. The pathway scheme displayed
    was generated with the Ingenuity Pathway Analysis (IPA) software (Ingenuity Systems
    Inc., Redwood City, CA, USA).
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PDGFA
  - PDGFB
  - PDGFC
  - PDGFD
  - IGF1
  - VEGFA
  - VEGFB
  - VEGFC
  - VEGFD
  - PGF
  - EGF
  - NF2
  - PLA2G1B
  - PLA2G2A
  - PLA2G6
  - PLA2G3
  - PLA2G5
  - PLA2G7
  - PLA2G10
  - PLA2G12A
  - PLA2G12B
  - PLA2G2C
  - PLA2G2D
  - PLA2G2E
  - PLA2G2F
  - PLA2G4A
  - PLA2G4C
  - PLA2G4D
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - KRAS
  - HRAS
  - NRAS
  - PTEN
  - JAK1
  - JAK2
  - JAK3
  - TYK2
  - PLCG1
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - AKT1
  - AKT2
  - AKT3
  - MTOR
  - PTGS2
  - MAPK1
  - MAPK3
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - RPS6KB1
  - RPS6KB2
  - ANXA6
  - UBASH3B
  - PRRT2
  - PRKCA
  - PRKCB
  - PRKCD
  - PRKCE
  - PRKCG
  - PRKCH
  - PRKCI
  - PRKCQ
  - PRKCZ
  - PRKD3
  - STAT3
  - ATP5F1A
  - E2F1
  - E2F2
  - E2F3
  - E2F4
  - E2F5
  - E2F6
  - E2F7
  - E2F8
  - TP53
  - CDKN2A
  - S100A9
  - CDK2AP2
  - SUB1
  - RPP14
  - LAMTOR2
  - SF3B6
  - H3P8
  - MEG3
  - NIBAN2
  - RB1
  - RBM45
  - CDKN1A
  - TCEAL1
  - NSG1
  - H3P16
  - CCND1
  - CCND2
  - CCND3
  - CDK4
  - CDK6
  - CDKN2B
  - CDKN2C
  - H3P10
  - MRPL28
  - NXT1
  - H3P9
  - PGE2
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Melanoma
  - Noonan syndrome
---
